Tender Details

Country: USA
Summary: Advancing Genomic Medicine Research (R21 Clinical Trial Optional)
UST Ref No: 110413548
Deadline: 11 Feb 2025
Financier: Self Financed
Purchaser Ownership: Government
Tender Value: Refer Document
Notice Type: Tender
Document Ref. No.: RFA-HG-25-003
Purchaser's Detail:
Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
Login to see details
Description:
The National Human Genome Research Institute Intends To Issue A Funding Opportunity Announcement (Foa) To Solicit Applications That Stimulate Innovation And Advance Understanding Of When, Where And How Best To Implement The Use And Sharing Of Genomic Information And Technologies In Clinical Care In All Persons Including Populations Or Communities That Experience Health Disparities, Such As Racial Or Ethnic Minority Groups, People With Lower Socioeconomic (Ses) Status, Underserved Rural Communities, And Sexual And Gender Minority Groups. The Intended Foa Will Be Based On A Concept Recently Approved By The National Advisory Council On Human Genome Research And Accompanying Discussion. This Notice Is Being Provided To Allow Potential Applicants Sufficient Time To Responsive Projects. Details Of The Planned Foa Are Provided Below.
Documents:

If you are registered member, kindly login to view full details of this tender notice:

Advancing Genomic Medicine Research (R21 Clinical Trial Optional) - USA Tender

The NATIONAL INSTITUTES OF HEALTH, a Government sector organization in USA, has announced a new tender for Advancing Genomic Medicine Research (R21 Clinical Trial Optional). This tender is published on USARFP under UST Ref No: 110413548 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2025-02-11.

The estimated tender value is Refer Document, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.